COMMUNIQUÉS West-GlobeNewswire
-
Grant of Restricted Stock Units and Warrants to Employees in Genmab
11/06/2026 -
VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor
11/06/2026 -
Sharecare wins 14 Digital Health Awards in Spring 2026 competition
11/06/2026 -
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
11/06/2026 -
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
11/06/2026 -
Spectral AI to Participate in 2026 British Burn Association Annual Conference
11/06/2026 -
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
11/06/2026 -
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
11/06/2026 -
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
11/06/2026 -
Arizona Nonprofit Launches “America 250” Fundraiser Featuring 250 Winners to Support Childhood Blindness Research
11/06/2026 -
EmblemHealth's Environmental Resilience Program Show Promising Results in Helping New Yorkers Reduce Heat-Related Risks and Hospitalizations
11/06/2026 -
Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients
11/06/2026 -
Announcing the 2026 Hall of Fame Philadelphia Titan 100 Honorees
11/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
11/06/2026 -
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
11/06/2026 -
KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare
11/06/2026 -
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
11/06/2026 -
BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events
11/06/2026 -
Ally Medical ER Is Headed to Pflugerville
11/06/2026
Pages